Purchase Order N3239821P0713
- Not listed
- <p>The Department of the Navy Bureau of Medicine and Surgery awarded Werfen USA LLC a $26,850 firm fixed price delivery order for consumables for the Roche Diagnostics Rotem Delta analyzer. The order, which does not have a set-aside designation, is for supplies to support laboratory testing equipment and has a period of performance through October 2, 2019. Werfen USA LLC will provide the consumable items as the prime contractor from their place of performance in Bedford, Massachusetts.</p>
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order contract to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $120,825 contract is for the delivery of unspecified products to support the agency's healthcare programs at the Fort Sam Houston location in Texas. The contract is not set aside for any specific business type. Werfen USA LLC provides specialized medical devices, consumables, and support to...
- The Department of Veterans Affairs (VA) awarded a $129,957.89 firm fixed price purchase order to Werfen USA LLC, a for-profit limited liability company and manufacturer of in vitro diagnostic equipment, for the supply of WERFEN TEM PRODUCTS USED ON THE ROTEM COAGULATION ANALYZER. This award is not associated with a set-aside program. The products will support coagulation testing at VA medical facilities within Veterans Integrated Service Network 22. Werfen USA LLC holds various contracts with...
- The Department of the Navy Bureau of Medicine and Surgery awarded Werfen USA LLC a $4,827 firm fixed price delivery order for GEM4000 150 tests. The contract has a period of performance through June 16, 2022 in Bedford, Massachusetts and was awarded on the same date without a set-aside designation. As a provider of in vitro diagnostics for hemostasis testing and clinical chemistry, Werfen will deliver its GEM4000 analyzer tests to support the Bureau's medical equipment and laboratory services...
- This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care settings. The contract, valued at $94,298.75, is for the delivery of ROTEM reagents. It has an ultimate completion date of September 30, 2020 and was awarded on October 1, 2017. The contract does not have a set-aside designation. Werfen USA LLC is an established prime...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The contract, valued at $82,650.00, is for the ROTEM product line, which includes coagulation analyzers, reagents, and supplies to support blood coagulation testing programs for veterans. This award is not set aside for any specific business type. Werfen USA holds...
- The U.S. Department of the Army Medical Command awarded a $102,573.50 firm fixed price purchase order contract to Werfen USA LLC, a for-profit limited liability company that manufactures in vitro diagnostic equipment, reagents, and services. The contract is for the delivery of coagulation reagents and analyzers, with a period of performance ending on September 30, 2019. This contract does not have a set-aside designation. Werfen USA LLC is an established supplier of diagnostic equipment and...
- The Defense Health Agency awarded a $108,657.52 delivery order to Werfen USA LLC for blood coagulation analyzer and reagents with a performance period from October 1, 2025 through September 30, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, and performance will occur at a location in Fayetteville, North Carolina. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory...
- The Defense Health Agency awarded a $714.7K firm fixed-price purchase order to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, for blood coagulation testing supplies and support services. This contract, which commenced on October 1, 2020, and extends through September 30, 2025, involves the delivery of two fully automated benchtop coagulation analyzer systems capable of performing comprehensive assays including...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, received a contract award on December 1, 2021, for coagulation cost-per-reportable-result (CPRR) testing services at Hines Base Period through Veterans Integrated Service Network 12. This Blanket Purchase Agreement (BPA) call, issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III), carries a ceiling value of $158,713 and is structured as a firm fixed-price delivery...
The U.S. Navy's Bureau of Medicine and Surgery awarded a $114.3K firm fixed-price purchase order to Werfen USA LLC on September 14, 2021, for research support related to trauma and controlled-hemorrhagic shock management. The contract requires standardized, qualitative approaches to clot characterization and hemostasis analysis using ROTEM technology, which measures and analyzes FDA-approved coagulation and clotting assays in whole blood samples. Performance is based in San Antonio, Texas, with an ultimate completion date of September 13, 2026. This award was not designated as a set-aside contract. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, brings extensive experience in providing advanced medical diagnostic technologies to federal healthcare agencies. The company specializes in coagulation analyzers, blood gas analyzers, and related laboratory consumables, with established relationships across the Department of Veterans Affairs, Defense Health Agency, and other federal medical systems. This contract aligns with the Navy's medical research and operational readiness mission by supporting critical hemostasis testing capabilities essential for trauma management in military medical settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Other Administrative Action | $0 | 6/18/25 | |
| P00006 | Exercise an Option | $20.7k | 6/12/25 | |
| P00005 | Other Administrative Action | $0 | 3/25/25 | |
| P00004 | Exercise an Option | $20.7k | 8/22/24 | |
| P00003 | Exercise an Option | $20.7k | 8/18/23 |